Oncology studies demand a specialized team who understands and can readily execute the scientific and regulatory issues that are most relevant to the program. Our oncology teams are built to work quickly, tactically and honestly with Sponsor and sites in a partnership philosophy. Focused oncology teams allow effective trial planning and execution from protocol development to database lock. Clinlogix works proactively to identify potential issues of concern, and provides solutions for the most efficient and successful trial.
With experience in trials from early through late phase development (Phase I – IV), including classic multi-cytotoxic agent and targeted and/or biologic therapy trials, the oncologic experts at Clinlogix deliver rapid and accurate results in trials of varied scope – from small, focused trials to large global studies.
There is an urgent need to develop new oncologic therapies. But oncology clinical trials are longer and more complex than those in any other therapeutic area. The complexity of development demands the right kind of research partner. Powerful solutions demand the thought leaders at Clinlogix.
Our team has successfully worked on oncology projects both commercially and investigator initiated trials (IIT) in following indications:
- Breast Cancer
- Bladder Cancer
- Colon/Rectal Cancer
- Lung Cancer
- Pancreatic Cancer
- Prostate Cancer
- Ovarian Cancer